146 related articles for article (PubMed ID: 38444445)
1. Feasibility and acceptability of the smart pillbox and medication label with differentiated care to support person-centered tuberculosis care among ASCENT trial participants - A multicountry study.
Tadesse AW; Mganga A; Dube TN; Alacapa J; van Kalmthout K; Letta T; Mleoh L; Garfin AMC; Maraba N; Charalambous S; Foster N; Jerene D; Fielding KL
Front Public Health; 2024; 12():1327971. PubMed ID: 38444445
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of implementation and effectiveness of digital adherence technology with differentiated care to support tuberculosis treatment adherence and improve treatment outcomes in Ethiopia: a study protocol for a cluster randomised trial.
Tadesse AW; Mohammed Z; Foster N; Quaife M; McQuaid CF; Levy J; van Kalmthout K; van Rest J; Jerene D; Abdurhman T; Yazew H; Umeta DG; Assefa D; Weldemichael GT; Bedru A; Letta T; Fielding KL
BMC Infect Dis; 2021 Nov; 21(1):1149. PubMed ID: 34758737
[TBL] [Abstract][Full Text] [Related]
3. Risk factors for poor engagement with a smart pillbox adherence intervention among persons on tuberculosis treatment in Ethiopia.
Tadesse AW; Cusinato M; Weldemichael GT; Abdurhman T; Assefa D; Yazew H; Gadissa D; Shiferaw A; Belachew M; Sahile M; van Rest J; Bedru A; Foster N; Jerene D; Fielding KL
BMC Public Health; 2023 Oct; 23(1):2006. PubMed ID: 37838677
[TBL] [Abstract][Full Text] [Related]
4. Digital Adherence Technologies Linked to Mobile Money Incentives for Medication Adherence Among People Living With Tuberculosis: Mixed Methods Feasibility and Acceptability Study.
Musiimenta A; Tumuhimbise W; Atukunda E; Mugaba A; Linnemayr S; Haberer J
JMIR Hum Factors; 2024 May; 11():e47996. PubMed ID: 38819905
[TBL] [Abstract][Full Text] [Related]
5. Evaluating the equity impact and cost-effectiveness of digital adherence technologies with differentiated care to support tuberculosis treatment adherence in Ethiopia: protocol and analysis plan for the health economics component of a cluster randomised trial.
Foster N; Tadesse AW; McQuaid CF; Gosce L; Abdurhman T; Assefa D; Bedru A; Houben RMGJ; van Kalmthout K; Letta T; Mohammed Z; van Rest J; Umeta DG; Weldemichael GT; Yazew H; Jerene D; Quaife M; Fielding KL
Trials; 2023 Apr; 24(1):292. PubMed ID: 37095533
[TBL] [Abstract][Full Text] [Related]
6. Acceptability and feasibility of digital adherence technologies for drug-susceptible tuberculosis treatment supervision: A meta-analysis of implementation feedback.
Guzman K; Crowder R; Leddy A; Maraba N; Jennings L; Ahmed S; Sultana S; Onjare B; Shilugu L; Alacapa J; Levy J; Katamba A; Kityamuwesi A; Bogdanov A; Gamazina K; Cattamanchi A; Khan A
PLOS Digit Health; 2023 Aug; 2(8):e0000322. PubMed ID: 37582066
[TBL] [Abstract][Full Text] [Related]
7. Acceptability of a Digital Adherence Tool Among Patients With Tuberculosis and Tuberculosis Care Providers in Kilimanjaro Region, Tanzania: Mixed Methods Study.
Mtenga AE; Maro RA; Dillip A; Msoka P; Emmanuel N; Ngowi K; Sumari-de Boer M
Online J Public Health Inform; 2024 Jun; 16():e51662. PubMed ID: 38922643
[TBL] [Abstract][Full Text] [Related]
8. Electronic pillbox-enabled self-administered therapy versus standard directly observed therapy for tuberculosis medication adherence and treatment outcomes in Ethiopia (SELFTB): protocol for a multicenter randomized controlled trial.
Manyazewal T; Woldeamanuel Y; Holland DP; Fekadu A; Blumberg HM; Marconi VC
Trials; 2020 May; 21(1):383. PubMed ID: 32370774
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness of digital adherence technologies in improving tuberculosis treatment outcomes in four countries: a pragmatic cluster randomised trial protocol.
Jerene D; Levy J; van Kalmthout K; Rest JV; McQuaid CF; Quaife M; Charalambous S; Gamazina K; Garfin AMC; Mleoh L; Terleieva Y; Bogdanov A; Maraba N; Fielding K
BMJ Open; 2023 Mar; 13(3):e068685. PubMed ID: 36918242
[TBL] [Abstract][Full Text] [Related]
10. Barriers and Facilitators to Implementing a Digital Adherence Technology for Tuberculosis Treatment Supervision in Uganda: Qualitative Study.
Leddy A; Ggita J; Berger CA; Kityamuwesi A; Sanyu AN; Tinka LK; Crowder R; Turyahabwe S; Katamba A; Cattamanchi A
J Med Internet Res; 2023 May; 25():e38828. PubMed ID: 37252774
[TBL] [Abstract][Full Text] [Related]
11. Implementation, feasibility, and acceptability of 99DOTS-based supervision of treatment for drug-susceptible TB in Uganda.
Kiwanuka N; Kityamuwesi A; Crowder R; Guzman K; Berger CA; Lamunu M; Namale C; Kunihira Tinka L; Nakate AS; Ggita J; Turimumahoro P; Babirye D; Oyuku D; Patel D; Sammann A; Turyahabwe S; Dowdy DW; Katamba A; Cattamanchi A
PLOS Digit Health; 2023 Jun; 2(6):e0000138. PubMed ID: 37390077
[TBL] [Abstract][Full Text] [Related]
12. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
13. Digital Adherence Technologies and Mobile Money Incentives for Management of Tuberculosis Medication Among People Living With Tuberculosis: Mixed Methods Formative Study.
Musiimenta A; Tumuhimbise W; Atukunda E; Mugaba A; Linnemayr S; Haberer J
JMIR Form Res; 2023 Apr; 7():e45301. PubMed ID: 37043263
[TBL] [Abstract][Full Text] [Related]
14. Implementation and effectiveness of evriMED with short messages service (SMS) reminders and tailored feedback compared to standard care on adherence to treatment among tuberculosis patients in Kilimanjaro, Tanzania: proposal for a cluster randomized controlled trial.
Sumari-de Boer M; Pima FM; Ngowi KM; Chelangwa GM; Mtesha BA; Minja LM; Semvua HH; Mpagama S; Mmbaga BT; Nieuwkerk PT; Aarnoutse RE
Trials; 2019 Jul; 20(1):426. PubMed ID: 31300028
[TBL] [Abstract][Full Text] [Related]
15. Acceptability of using the medication monitor and experience of a differentiated care approach for TB treatment adherence among people living with TB in South Africa.
Mukora R; Ahumah B; Maraba N; Orrell C; Jennings L; Naidoo P; Fielding KL; Velen K; Charalambous S; Chetty-Makkan CM
PLOS Glob Public Health; 2023; 3(10):e0001885. PubMed ID: 37889875
[TBL] [Abstract][Full Text] [Related]
16. Time Trend Analysis of Tuberculosis Treatment While Using Digital Adherence Technologies-An Individual Patient Data Meta-Analysis of Eleven Projects across Ten High Tuberculosis-Burden Countries.
de Groot LM; Straetemans M; Maraba N; Jennings L; Gler MT; Marcelo D; Mekoro M; Steenkamp P; Gavioli R; Spaulding A; Prophete E; Bury M; Banu S; Sultana S; Onjare B; Efo E; Alacapa J; Levy J; Morales MLL; Katamba A; Bogdanov A; Gamazina K; Kumarkul D; Ekaterina OL; Cattamanchi A; Khan A; Bakker MI
Trop Med Infect Dis; 2022 Apr; 7(5):. PubMed ID: 35622692
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of adherence monitoring system using evriMED with a differentiated response compared to standard of care among drug-sensitive TB patients in three provinces in South Africa: a protocol for a cluster randomised control trial.
Maraba N; Orrell C; Chetty-Makkan CM; Velen K; Mukora R; Page-Shipp L; Naidoo P; Mbatha MT; Fielding KL; Charalambous S
Trials; 2021 Jun; 22(1):389. PubMed ID: 34108036
[TBL] [Abstract][Full Text] [Related]
18. Qualitative study exploring the feasibility of using medication monitors and a differentiated care approach to support adherence among people receiving TB treatment in South Africa.
Mukora R; Maraba N; Orrell C; Jennings L; Naidoo P; Mbatha MT; Velen K; Fielding K; Charalambous S; Chetty-Makkan CM
BMJ Open; 2023 Mar; 13(3):e065202. PubMed ID: 36868589
[TBL] [Abstract][Full Text] [Related]
19. Acceptability of the Medication Event Reminder Monitor for Promoting Adherence to Multidrug-Resistant Tuberculosis Therapy in Two Indian Cities: Qualitative Study of Patients and Health Care Providers.
Thomas BE; Kumar JV; Periyasamy M; Khandewale AS; Hephzibah Mercy J; Raj EM; Kokila S; Walgude AS; Gaurkhede GR; Kumbhar JD; Ovung S; Paul M; Rajkumar BS; Subbaraman R
J Med Internet Res; 2021 Jun; 23(6):e23294. PubMed ID: 34110300
[TBL] [Abstract][Full Text] [Related]
20. Feasibility and acceptability of an innovative adherence intervention for young adults with childhood-onset systemic Lupus Erythematosus.
Harry O; Crosby LE; Mara C; Ting TV; Huggins JL; Modi AC
Pediatr Rheumatol Online J; 2020 Apr; 18(1):36. PubMed ID: 32340616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
